Combined therapy with cardiac contractility modulation and subcutaneous implantable cardioverter-defibrillator: the first experience in Poland
Krzysztof Kaczmarek(Medical University of Lodz), Paweł Ptaszyński(Medical University of Lodz), Michał Kałowski(Medical University of Lodz), Jerzy Krzysztof Wranicz(Medical University of Lodz)
Cited by 2
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|European Heart Journal|2018|285
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy
|EP Europace|2012|107
Quantitative Assessment of Microvolt T‐Wave Alternans in Patients with Congestive Heart Failure
|Journal of Cardiovascular Electrophysiology|2005|84